Cancer scientists have combined 'liquid biopsy,' epigenetic alterations and machine learning to develop a blood test to detect and classify cancer at its earliest stages.
from All Top News -- ScienceDaily https://www.sciencedaily.com/releases/2018/11/181114132000.htm
from All Top News -- ScienceDaily https://www.sciencedaily.com/releases/2018/11/181114132000.htm
Comments
Post a Comment
Thank you for your message. We are improving our services everyday.